InvestorWire NewsRoom

Article

Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) Welcomes Tougher Vape Regulations as FDA Nears Major PMTA Announcement
August 23, 2021

Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) Welcomes Tougher Vape Regulations as FDA Nears Major PMTA Announcement

  • One year after the deadline for submitting Premarket Tobacco Product Applications, the FDA is targeting September 9, 2021 for an announcement on which products will be allowed for sale
  • Kaival is the exclusive global distributor for products made by BIDI Vapor, which has seen its PMTAs pass two out of three phases in the FDA process
  • Kaival competition was recently thinned considerably when the FDA rejected approximately 4.5 million of the 6.5 million PMTAs received

Despite efforts by the U.S. Food and Drug Administration in recent years to implement and enforce new regulation governing e-cigarette market, illegal goods and practices still abound. The days of illicit nicotine products may be dwindling down, representing a paradigm shift supported by companies like Kaival Brands Innovations Group (NASDAQ: KAVL) that are deeply committed to seeing only safe, 21-years and older use of vape products. Kaival, the exclusive global distributor of a portfolio of premium vape products manufactured by BIDI Vapor, LLC.

Last year, the FDA set September 9, 2020 as the deadline for companies to submit Premarket Tobacco Product Applications (“PMTA”) seeking authorization to market specific tobacco products. The long-and-short of new regulations is that there are only three ways to legally sell a tobacco product: one: a product can be grandfathered in by having been on the market before February 15, 2007; two: a brand can receive FDA approval to a Substance Equivalence application deeming a product similar to a grandfathered in product; and three,  through submission of a PMTA, which identifies the product as introduced to the market after February 15, 2007 and unlike any grandfathered in. A company was required to submit a PMTA for every product it wishes to sell, including a separate PMTA for every different e-liquid flavor and device. This is the pathway for BIDI Vapor and its BIDI Stick electronic nicotine delivery systems (“ENDS”) product lineup that come in 11 different flavors. 

BIDI’s PMTAs have passed the first two phases: receiving an acceptance letter from the FDA for the PMTA and subsequently receiving a filing letter indicating the application has met the FDA’s baseline criteria, allowing it to move into the final phase. The “substantive” phase involves the FDA’s scientific review of the PMTA (https://ibn.fm/WI59h) and associated data. BIDI and Kaival are waiting for a final decision in the coming weeks, with an approval officially designating the products as “appropriate for the protection of public health.”

The FDA received over 6.5 million PMTAs from over 500 countries by the deadline which are now under review, with a target completion date of September 9, 2021. The list was trimmed by over 70% on August 9, 2021 when the FDA issued a Refuse to File (“RTF”) letter to JD Nova Group LLC, the owner of Vapolocity (https://ibn.fm/Zy8o9). The RTF stated that the applications for approximately 4.5 million JD Nova products “lacked an adequate Environmental Assessment,” meaning that they will have to be removed from the market or risk enforcement action by FDA. The RTF effectively dismissed 75% of the new products looking to make it to market.

Kaival and BIDI, with their industry-leading regulatory and youth access prevention practices, continue to be relentless advocates for increased regulatory oversite to ensure e-cigarette products do not reach the hands of consumers under 21 years old, and are recycled, when possible, through their BIDI cares program. As the major FDA PMTA announcement approaches, some unethical companies are dumping their product into the markets before the crackdown and stiffer law enforcement begins. Ultimately, the announcement will determine which companies can remain on the market in a bit of a cleansing to weed out the industry’s bad actors for the good of public safety.

“We place enormous importance on our integrity and our brand name,” said Nirajkumar “Raj” Patel, Founder and Chief Executive Officer of Kaival Brands. Patel, which also owns and controls BIDI Vapor, added, “not only are we ready for increased regulation and enforcement, we both encourage and welcome it.”

For more information, visit the company’s website at www.KaivalBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to KAVL are available in the company’s newsroom at http://ibn.fm/KAVL 

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).